Co‐testing in cervical screening among 40‐ to 42‐year‐old women is unreasonable
Abstract Introduction The screening program for cervical cancer in Sweden recommends the use of primary human papillomavirus (HPV) screening for women aged ≥30 to 65 years. Co‐testing with both HPV analysis and cytology is recommended at the first screening after the age of 40 years. To fulfil co‐te...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-03-01
|
| Series: | Acta Obstetricia et Gynecologica Scandinavica |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/aogs.14311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|